Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Rubius Therapeutics patents

List of Rubius Therapeutics patents

List of Bristol-Myers Squibb patents

List of Inbiomotion patents

List of CRISPR Therapeutics patents

List of George Mason University patents

List of companies in RusnanoMedInvest's investment portfolio

Patents where

Current Assignee

Name

is

Rubius Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10456421 Compositions and methods related to engineered erythoid cells comprising 4-1BBL	Patent 10456421 was granted and assigned to Rubius Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10456421	October 29, 2019
	‌ US Patent 10517897 Methods related to engineered erythoid cells comprising 4-1BBL	Patent 10517897 was granted and assigned to Rubius Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10517897	December 31, 2019
	‌ US Patent 10329531 Synthetic membrane-receiver complexes	Patent 10329531 was granted and assigned to Rubius Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10329531	June 25, 2019
	‌ US Patent 11020435 Functionalized erythroid cells	Patent 11020435 was granted and assigned to Rubius Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	11020435	June 1, 2021
	‌ US Patent 10253296 Synthetic membrane-receiver complexes	Patent 10253296 was granted and assigned to Rubius Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10253296	April 9, 2019
	‌ US Patent 11554141 Methods and compositions for immunomodulation	Patent 11554141 was granted and assigned to Rubius Therapeutics on January, 2023 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	11554141	January 17, 2023
	‌ US Patent 11576934 Methods and compositions for immunomodulation	Patent 11576934 was granted and assigned to Rubius Therapeutics on February, 2023 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	11576934	February 14, 2023
	‌ US Patent 10557119 Erythroid cells comprising phenylalanine ammonia lyase	Patent 10557119 was granted and assigned to Rubius Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10557119	February 11, 2020
	‌ US Patent 10869898 Methods and compositions for immunomodulation	Patent 10869898 was granted and assigned to Rubius Therapeutics on December, 2020 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10869898	December 22, 2020
	‌ US Patent 10301594 Synthetic membrane-receiver complexes	Patent 10301594 was granted and assigned to Rubius Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10301594	May 28, 2019
	‌ US Patent 10301593 Synthetic membrane-receiver complexes	Patent 10301593 was granted and assigned to Rubius Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10301593	May 28, 2019
	‌ US Patent 10344263 Synthetic membrane-receiver complexes	Patent 10344263 was granted and assigned to Rubius Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10344263	July 9, 2019
	‌ US Patent 10568910 Compositions and methods related to engineered erythroid cells comprising IL-15	Patent 10568910 was granted and assigned to Rubius Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10568910	February 25, 2020
	‌ US Patent 9644180 Synthetic membrane-receiver complexes	Patent 9644180 was granted and assigned to Rubius Therapeutics on May, 2017 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	9644180	May 9, 2017
	‌ US Patent 10716811 Compositions and methods related to multimodal therapeutic cancer indications		Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	10716811	July 21, 2020
	‌ US Patent 11141433 Therapeutic cell systems and methods for treating cancer and infectious diseases	Patent 11141433 was granted and assigned to Rubius Therapeutics on October, 2021 by the United States Patent and Trademark Office.	Rubius Therapeutics	Rubius Therapeutics		United States Patent and Trademark Office	11141433	October 12, 2021

16 results

0 selected

16 results

0 selected